April 20, 2017 | MeMed, an Israeli start-up developing a reliable test to distinguish bacterial from viral infections, has secured a $9.2 million contract by the Defense Threat Reduction Agency (DTRA), a branch of the US Department of Defense (DoD) to improve clinical applications of its technology. The contract will fund the completion of MeMed’s pioneering point of […]